{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreighhgvam32fd67kvg6qrq4ywu7ayxmzw52vhev53uobqgywhtlsve",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mn43ih6343e2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig64p2ega5idyyhyqt6tjfosdiyqvo3tglalzcozx7rqypdhsvcyu"
    },
    "mimeType": "image/jpeg",
    "size": 93321
  },
  "path": "/news/2026-05-ai-approach-aims-dose-therapy.html",
  "publishedAt": "2026-05-30T18:10:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "A new machine-learning approach for prostate-specific membrane antigen (PSMA) treatment of metastatic castration-resistant prostate cancer (mCRPC) could estimate radiation dose to tumors and healthy organs before therapy begins. Using data already available from pre-therapy PET/CT scans, this novel prediction tool could help personalize treatment plans, improve patient selection, and reduce toxicity risk.",
  "title": "New AI approach aims to predict radiation dose before therapy in advanced prostate cancer"
}